Part 4 Amendments to the Medical Devices (Northern Ireland Protocol) Regulations 2021
- 27Amendment to the Medical Devices (Northern Ireland Protocol) Regulations 2021
- 28Amendment to regulation 2 (extent and application)
- 29Amendment to regulation 3 (interpretation)
- 30Amendment to regulation 4 (scope)
- 31Amendment to regulation 8 (certificates of free sale – fee)
- 32Amendment to regulation 10 (UK(NI) indication)
- 33New Part 2A (Making available on the market and putting into service under Regulation (EU) 2017/746)
- 34New regulation A11 (legal representatives and contact persons for clinical investigations)
- 35Amendment to regulation 13 (arbitration following the refusal of a clinical investigation application)
- 36New Part 3A (Performance studies under Regulation (EU) 2017/746)
- 37Amendment to Part 4
- 38Amendment to regulation 18 (notified bodies)
- 39Amendment to regulation 19 (fees payable in connection with the designation of notified bodies)
- 40Amendment to regulation 20 (language requirements)
- 41Amendment to regulation 23 (offence of breaching certain provisions)
- 42Amendment to regulation 26 (enforcement)
- 43Amendment to Schedule 2 (fees in connection with the designation of notified bodies)
- 44Amendment to Schedule 3 (provisions breach of which is an offence under regulation 23)